{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:36:19Z","timestamp":1777451779404,"version":"3.51.4"},"reference-count":59,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Therapy"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:p>The effectiveness of current antiretroviral therapies has led to more patients receiving long-term therapy, and increasing numbers of older patients. The complex interactions between HIV infection, ageing, comorbid conditions and drug-related toxicities, and their combined effects on patient health and quality of life, were the subject of the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV. Key topics included the metabolic effects of antiretroviral agents, cardiovascular disease, bone metabolism and age-related changes in disease and response to drug therapy. Data presented at the meeting refect the growing recognition of common pathways that contribute to progression of mutiple types of disease and adverse drug reactions.<\/jats:p>","DOI":"10.3851\/imp1470","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T13:07:59Z","timestamp":1260536879000},"page":"1195-1208","source":"Crossref","is-referenced-by-count":4,"title":["Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV"],"prefix":"10.1177","volume":"14","author":[{"given":"Richard E","family":"Boehme","sequence":"first","affiliation":[{"name":"International Medical Press, Hamilton, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Cameron","sequence":"additional","affiliation":[{"name":"International Medical Press, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2009,11,1]]},"reference":[{"key":"bibr1-IMP1470","first-page":"229","volume":"170","author":"Montessori V.","year":"2004","journal-title":"CMAJ"},{"key":"bibr2-IMP1470","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041811"},{"key":"bibr3-IMP1470","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1177\/135965350901401S01","volume":"14","author":"Bacchetti P.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr4-IMP1470","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000182230.47819.aa"},{"key":"bibr5-IMP1470","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000229996.75116.da"},{"key":"bibr6-IMP1470","first-page":"A8","volume":"14","author":"Puls R.L.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr7-IMP1470","first-page":"A17","volume":"14","author":"Ionescu G.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr8-IMP1470","first-page":"A27","volume":"14","author":"Vrouenraets S.M.E.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr9-IMP1470","first-page":"A51","volume":"14","author":"Podzamczer D.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr10-IMP1470","first-page":"A27","volume":"14","author":"Alam N.M.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr11-IMP1470","first-page":"A9","volume":"14","author":"Gathercole L.L.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr12-IMP1470","first-page":"A10","volume":"14","author":"McGee K.C.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr13-IMP1470","first-page":"A10","volume":"14","author":"Distler O.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr14-IMP1470","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.1177\/135965350901400104","volume":"14","author":"Martone S.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr15-IMP1470","doi-asserted-by":"crossref","first-page":"A11","DOI":"10.3851\/IMP1296","volume":"14","author":"Stankov M.V.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr16-IMP1470","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-07-0133"},{"key":"bibr17-IMP1470","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.1177\/135965350901400104","volume":"14","author":"Shikuma C.M.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr18-IMP1470","first-page":"A24","volume":"14","author":"Veloso S.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr19-IMP1470","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03603.x"},{"key":"bibr20-IMP1470","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1177\/135965350901401S01","volume":"14","author":"Lo J.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr21-IMP1470","unstructured":"Falutz J., Mamputu J-C, Potvin Soulban G., Grinspoon S. Metabolic effects of tesamorelin (TH9507), a growth hormone-releasing factor analogue, in HIV-infected patients with excess abdominal fat. a pooled analysis of 2 multicenter, double-blind placebo-controlled Phase 3 trials with 816 randomized patients.\n                      18th Annual Canadian Conference on HIV\/AIDS Research\n                      . 23\u201326 April 2009, Vancouver, BC, Canada. Abstract O070."},{"key":"bibr22-IMP1470","first-page":"A4","volume":"14","author":"Turner R.R.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr23-IMP1470","first-page":"A5","volume":"14","author":"Bastard J-P","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr24-IMP1470","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.3851\/IMP1300","volume":"14","author":"Brown T.T.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr25-IMP1470","first-page":"A7","volume":"14","author":"Kim P.S.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr26-IMP1470","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.11.073"},{"key":"bibr27-IMP1470","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-102269"},{"key":"bibr28-IMP1470","first-page":"A7","volume":"14","author":"Vyas A.K.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr29-IMP1470","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00550.2006"},{"key":"bibr30-IMP1470","first-page":"A25","volume":"14","author":"Saeedi R.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr31-IMP1470","unstructured":"Ganz P. Non-invasive assessment of atherosclerosis \u2013 are measurements of endothelial function and carotid IMT useful?\n                      11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV\n                      . 26\u201328 October 2009, Philadelphia, PA, USA. Available from http:\/\/broadcast.sztream.com\/1515174\/lipo2009\/Index.html."},{"key":"bibr32-IMP1470","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198610233151702"},{"key":"bibr33-IMP1470","first-page":"A11","volume":"14","author":"Guaraldi G.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr34-IMP1470","first-page":"A12","volume":"14","author":"Richardson R.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr35-IMP1470","doi-asserted-by":"crossref","first-page":"A54","DOI":"10.3851\/IMP1291","volume":"14","author":"Young B.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr36-IMP1470","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1177\/135965350901400107","volume":"14","author":"Hileman C.O.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr37-IMP1470","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09607-1"},{"key":"bibr38-IMP1470","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1177\/135965350901400107","volume":"14","author":"Cade W.T.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr39-IMP1470","unstructured":"Rader D. Inflammation and atherosclerosis. Presented at:\n                      11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV\n                      . 26\u201328 October 2009, Philadelphia, PA, USA."},{"key":"bibr40-IMP1470","first-page":"A14","volume":"14","author":"Cotter E.J.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr41-IMP1470","first-page":"A14","volume":"14","author":"Moyle G.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr42-IMP1470","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.2.191"},{"key":"bibr43-IMP1470","unstructured":"Welz T., Childs K., Ibrahim F., Poulton M., Post F. Efavirenz use is associated with severe vitamin D deficiency in a large, ethnically diverse urban UK HIV cohort.\n                      5th IAS Conference on HIV Pathogenesis, Treatment and Prevention\n                      . 19\u201322 July 2009, Cape Town, South Africa. Abstract TUPEB186."},{"key":"bibr44-IMP1470","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.3851\/IMP1300","volume":"14","author":"Brown T.T.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr45-IMP1470","first-page":"A16","volume":"14","author":"Effros R.B.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr46-IMP1470","first-page":"A31","volume":"14","author":"Falutz J.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr47-IMP1470","unstructured":"Guaraldi G., Zona S., Vescini F. Gender and gonadal function differences in the prevalence of bone mass reduction.\n                      16th Conference on Retroviruses and Opportunistic Infections\n                      . 8\u201311 February 2009, Montreal, QC, Canada. Abstract 754."},{"key":"bibr48-IMP1470","unstructured":"Liu A., Gvetadze R., Sellmeyer D., Grohskopf L., Buchbinder S. Low bone density among a population of healthy HIV-negative MSM screening for a pre-exposure prophylaxis trial.\n                      XVII International AIDS Conference\n                      . 3\u20138 August 2008, Mexico City, Mexico. Abstract THPE0169."},{"key":"bibr49-IMP1470","first-page":"A61","volume":"14","author":"Glover E.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr50-IMP1470","first-page":"A17","volume":"14","author":"Hulgan T.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr51-IMP1470","first-page":"A65","volume":"14","author":"Arenas-Pinto A.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr52-IMP1470","doi-asserted-by":"crossref","first-page":"A63","DOI":"10.1177\/135965350901400113","volume":"14","author":"Lebrecht D.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr53-IMP1470","first-page":"A61","volume":"14","author":"Blas-Garc\u00eda A.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr54-IMP1470","unstructured":"Campisi J. Ageing: the ultimate co-morbidity factor. Presented at:\n                      11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV\n                      . 26\u201328 October 2009, Philadelphia, PA, USA. Available from http:\/\/broadcast.sztream.com\/1515174\/lipo2009\/Index.html."},{"key":"bibr55-IMP1470","first-page":"A18","volume":"14","author":"Cotter E.J.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr56-IMP1470","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.3851\/IMP1300","volume":"14","author":"Brown T.T.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr57-IMP1470","first-page":"A5","volume":"14","author":"Jahanshad N.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr58-IMP1470","unstructured":"Biggar R. Does immunity control the expression of cancer? Learning from the experience of the HIV\/AIDS epidemic. Presented at:\n                      11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV\n                      . 26\u201328 October 2009, Philadelphia, PA, USA. Available from http:\/\/broadcast.sztream.com\/1515174\/lipo2009\/Index.html."},{"key":"bibr59-IMP1470","unstructured":"Sarrazin C. New antiviral drugs against HCV \u2013 adverse event profiles and pharmacokinetic interactions. Presented at:\n                      11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV\n                      . 26\u201328 October 2009, Philadelphia, PA, USA. Available from http:\/\/broadcast.sztream.com\/1515174\/lipo2009\/Index.html."}],"container-title":["Antiviral Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP1470","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP1470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:49:15Z","timestamp":1777380555000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3851\/IMP1470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.3851\/IMP1470"],"URL":"https:\/\/doi.org\/10.3851\/imp1470","relation":{},"ISSN":["1359-6535","2040-2058"],"issn-type":[{"value":"1359-6535","type":"print"},{"value":"2040-2058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}